- Home
- ICLR vs CNC Comparison
ICLR vs CNC Comparison
Compare ICLR & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | CNC |
|---|---|---|
| Founded | 1990 | 1984 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 18.5B |
| IPO Year | 1998 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ICLR | CNC |
|---|---|---|
| Price | $185.88 | $38.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 17 |
| Target Price | ★ $201.23 | $40.06 |
| AVG Volume (30 Days) | 1.0M | ★ 8.4M |
| Earning Date | 10-22-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.47 | N/A |
| Revenue | $8,102,602,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | $0.76 | $0.19 |
| P/E Ratio | $24.87 | ★ N/A |
| Revenue Growth | N/A | ★ 14.57 |
| 52 Week Low | $125.10 | $25.08 |
| 52 Week High | $228.29 | $66.81 |
Technical Indicators
Market Signals| Indicator | ICLR | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 55.23 |
| Support Level | $174.13 | $37.41 |
| Resistance Level | $191.15 | $39.34 |
| Average True Range (ATR) | 8.46 | 1.38 |
| MACD | 2.87 | 0.07 |
| Stochastic Oscillator | 85.77 | 70.49 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.